EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Game Changer or More of the Same? A Comparative Meta-Analysis of Rezafungin and Caspofungin in Treating Candidemia and Invasive Candidiasis

Zouina Sarfraz, Zeeshan Nasir, Faheem Javad, Aden Khan, Bushra Shah, Musfira Khalid, Azza Sarfraz, Muzna Sarfraz, Amna Minhas, Suchal A Gondal

Journal of Community Hospital Internal Medicine Perspectives · 09.09.2024 · 14 (5) · 1-6

DOI: 10.55729/2000-9666.1391 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Community Hospital Internal Medicine Perspectives, online erschienen am 09.09.2024. Verfasst von Zouina Sarfraz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fatima Jinnah Medical University, Lahore, Pakistan. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This meta-analysis assesses the recent Food and Drug Administration (FDA)-approved antifungal, rezafungin, for treating candidemia and invasive candidiasis— both are significant health concerns with limited treatment options. Two randomized controlled trials comparing rezafungin to caspofungin were meta-analyzed, revealing no significant differences in global cure rates and 30-day all-cause mortality. While rezafungin's unique attributes, like a novel mechanism and once-weekly dosing, may enhance patient adherence, concerns arise about its clinical relevance given the substantial investment. The study emphasizes the need for ongoing research, post-marketing surveillance, and real-world data to determine rezafungin's true value in managing these life-threatening fungal infections. Despite FDA approval, further investigation is warranted for a comprehensive understanding of rezafungin's efficacy and safety. Keywords: Rezafungin; Candidemia; Invasive candidiasis; Meta-analysis; Antifungal therapy

Schlagwörter

Stichwörter der Autor:innen

Antifungal therapyCandidemiaInvasive candidiasisMeta-analysisRezafungin

Autor:innen und Institutionen

  • Fatima Jinnah Medical University, Lahore, Pakistan.
  • Nishtar Medical University, Multan, Pakistan.
  • Al Nafees Medical College, Islamabad, Pakistan.
  • The Aga Khan University, Karachi, Pakistan.
  • King Edward Medical University, Lahore, Pakistan.
  • Rawalpindi Medical University, Rawalpindi, Pakistan.

Zitieren

APA

Sarfraz, Z., Nasir, Z., Javad, F., Khan, A., Shah, B., Khalid, M., Sarfraz, A., Sarfraz, M., Minhas, A., & Gondal, S. A. (2024). Game Changer or More of the Same? A Comparative Meta-Analysis of Rezafungin and Caspofungin in Treating Candidemia and Invasive Candidiasis. Journal of Community Hospital Internal Medicine Perspectives, 14(5), 1-6. https://doi.org/10.55729/2000-9666.1391

Vancouver

Sarfraz Z, Nasir Z, Javad F, Khan A, Shah B, Khalid M, et al. Game Changer or More of the Same? A Comparative Meta-Analysis of Rezafungin and Caspofungin in Treating Candidemia and Invasive Candidiasis. Journal of Community Hospital Internal Medicine Perspectives. 2024;14(5):1-6. doi:10.55729/2000-9666.1391

BibTeX
@article{Sarfraz2024,
  author = {Sarfraz, Zouina and Nasir, Zeeshan and Javad, Faheem and Khan, Aden and Shah, Bushra and Khalid, Musfira and Sarfraz, Azza and Sarfraz, Muzna and Minhas, Amna and Gondal, Suchal A},
  title = {Game Changer or More of the Same? A Comparative Meta-Analysis of Rezafungin and Caspofungin in Treating Candidemia and Invasive Candidiasis},
  journal = {Journal of Community Hospital Internal Medicine Perspectives},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {1--6},
  doi = {10.55729/2000-9666.1391}
}
Kostenlos starten →